The Fund has made commitments to the following underlying Funds:

5 AM Ventures II, L.P. - $150 Million;
Fund II focuses on seed and early-stage investments in life sciences

Allegis Capital Media Technology Venture V - $125 million;
Seed and early stage technology fund

Apax US VII, L.P. - $850 Million;
Fund VII focuses on buyouts in the retail & consumer, tech & telecom, healthcare, media and financial & business services industries

Ares Corporate Opportunities Fund III, L.P. - $3.5 billion;
Fund III focuses on middle market companies

Blackstone GSO - Focus is control and non-control distressed debt

Clarus Ventures II, L.P. - $660 Million;
Fund II focuses on healthcare and life science companies

Cross Creek Capital, L.P. - $111 Million;
Fund I focuses on late-stage investments across a broad spectrum of industries

Epic Venture Fund IV, L.L.C. - $100 Million;
Fund IV focuses on early stage information technology and life sciences investments

Fenway III - $702 million;
Buyout Fund focused on transportation logistics and brand development

Foundry I L.L.C. - $225 million;
Focused on seed and early stage information technology

Frazier Healthcare VI L.P. - $600 million;
Healthcare and biotechnology growth driven fund.

Highway 12 Ventures II, L.P. - $75 Million;
Fund II focuses on seed, early, and expansion stage investments across a broad spectrum of industries

Hummer Windblad IV, L.P. - $183 Million;
Focuses on SaaS technology, telecom and analytics.

Khosla Ventures III, L.P. - $750 million;
Focuses on multi-stage venture in the IT and cleantech sectors

Mercato Partners, L.P. - $150 Million;
Mercato is a stage agnostic, growth equity fund, targeting small to medium-sized businesses

New Enterprise Associates XIII, L.P. - $3.33 billion;
Focuses on late-stage, growth-equity and international investments with expertise in Energy, Healthcare, and Information Technology

Pine Brook I, L.P. - $1.43 billion;
Focused on growth capital investments in the energy and financial services sectors.

Rosewood Capital V, L.P. - $295 Million;
Fund V focuses on growth capital in the consumer and business services industries

RWI Ventures II, L.P. - $65 Million;
Fund II focuses on multi-stage investments in the technology and healthcare industries

Shasta Venture Group II - $250 million;
Focused on seed and early stage information technology

Sorenson II - $400 million;
Focuses on small to mid-market buyouts as well as growth-equity investments in Mountain West region

SV Life Sciences Fund IV, L.P. - $550 Million;
Fund IV focuses on multi-stage investments in most life sciences industries

TA XI, L.P. - $3.5 Billion;
Fund XI will focus on a similar growth equity / buyout approach.

Tri Ventures - Focuses on investing, developing and transitioning early stage medical technology opportunities

University Venture Fund - $18 Million;
Fund I is a co-investment fund focuses on seed and early-stage investments across a broad spectrum of industries

Upstart Life Sciences Capital, L.P. - $20 Million;
Upstart Ventures is focused on University life science spinouts

UV Partners IV - $119 million;
Convergence style fund focusing on health care and technology

vSpring II, L.P. - $85 Million;
Fund II focuses on seed and early stage investments in the technology, life science, communications and business services industries